Authors:
COMANDONE A
LEONE L
OLIVA C
FRUSTACI S
MONTELEONE M
COLUSSI AM
DALCANTON O
BERGNOLO P
BOGLIONE A
BUMMA C
Citation: A. Comandone et al., PHARMACOKINETICS OF IFOSFAMIDE ADMINISTERED ACCORDING TO 3 DIFFERENT SCHEDULES IN METASTATIC SOFT-TISSUE AND BONE SARCOMAS, Journal of chemotherapy, 10(5), 1998, pp. 385-393
Authors:
COMANDONE A
BOGLIONE A
DALCANTON O
BERGNOLO P
OLIVA C
BUMMA C
Citation: A. Comandone et al., IFOSFAMIDE (IFO) IN CONTINUOUS-INFUSION (CI) FOR 21 DAYS AS 2ND LINE THERAPY IN ADVANCED SARCOMAS - A PHASE-I STUDY, European journal of cancer, 33, 1997, pp. 499-499
Authors:
COMANDONE A
BOGLIONE A
BACCI G
OLIVA C
BERGNOLO P
LEONE L
FERRARI S
BUMMA C
Citation: A. Comandone et al., HIGH-DOSE METHOTREXATE (HDMTX) PHARMACOKINETIC PROFILE IN OSTEOSARCOMA PATIENTS, European journal of cancer, 33, 1997, pp. 1128-1128
Authors:
COMANDONE A
SELES E
BERGNOLO P
OLIVA C
BOGLIONE A
BERTETTO O
BUMMA C
Citation: A. Comandone et al., FLUOROURACIL (5-FU) AND LEVO-FOLINIC ACID (LFA) IN ELDERLY PATIENTS WITH ADVANCED COLORECTAL-CANCER - ACTIVE AND SAFE COMBINATION, European journal of cancer, 31A, 1995, pp. 715-715
Authors:
PAGANI A
SAPINO A
EUSEBI V
BERGNOLO P
BUSSOLATI G
Citation: A. Pagani et al., PIP GCDFP-15 GENE-EXPRESSION AND APOCRINE DIFFERENTIATION IN CARCINOMAS OF THE BREAST/, Virchows Archiv, 425(5), 1994, pp. 459-465